2028년까지 유럽 면역조직화학 시장 예측 – 애플리케이션(진단 및 약물 테스트), 제품(항체, 장비, 시약 및 키트), 최종 사용자(병원 및 진단 실험실, 연구소 및 기타)별 코로나19 영향 및 지역 분석

TIPRE00025747 | Pages: 160 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

시장 소개

유럽은 면역조직화학 분야에서 두 번째로 큰 시장이며, 영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 지역 유럽의 이 지역 시장에 주요 기여자입니다. 예측 기간 동안 독일이 시장을 주도했습니다. 독일에서는 최근 몇 년간 암 환자가 엄청나게 증가했습니다. 예를 들어, 글로벌 암 관측소(Global Cancer Observatory)에 따르면 2020년에는 남녀노소를 불문하고 총 6,28,519명의 신규 환자가 발견되었으며, 유방암은 69,697명(11.1%), 유방암 67,959명(10.8%)이 발생했습니다. 전립선암 64,804(10.3%) 폐암, 57,528(9.2%) 대장암, 35,147(5.6%) 방광암, 333,384(53%) 기타 암. 면역조직화학은 암의 진단 및 관리에 널리 사용됩니다. 따라서 국내에서는 면역조직화학에 대한 수요가 증가하고 있다. 국내에서 심혈관 질환의 유병률이 증가하고 있다. 노인 인구는 심혈관 질환의 유병률 증가에 크게 기여합니다. 인구통계학적 변화로 인해 환자 치료에 큰 어려움이 발생하고 있습니다. 인구 고령화와 함께 만성질환자 수도 꾸준히 증가하고 있다. 동시에 의료 부문의 비용 압박도 커지고 있습니다. 2019년 막스 플랑크 연구소(Max Planck Institute)에 따르면 우리나라 성인의 약 30~40%가 고혈압을 앓고 있습니다. 나이가 들수록 발병률이 증가하며, 60세 이상의 사람에서 심혈관계 질환이 발생할 가능성이 더 높습니다. IHC는 암, 감염성 질환, 심혈관 질환, 자가면역질환 등의 만성질환을 진단하는데 활용되기 때문에 임상진단 분야에서 점점 그 인기가 높아지고 있다. 따라서 만성질환 유병률 증가에 따라 면역조직화학 솔루션에 대한 수요가 증가해 시장 성장이 촉진될 것으로 예상된다.

유럽 국가, 특히 프랑스는 코로나19 사태로 큰 타격을 받고 있다. 코로나바이러스 면역조직화학 항체는 조류와 포유류를 감염시키는 코로나바이러스과 RNA 바이러스 계열의 구성원을 식별하는 데 사용할 수 있는 면역학적 방법입니다. SARS-CoV-2, SARS-CoV, MERS 및 고양이 코로나바이러스와 같은 기타 비인간 병원체와 같은 여러 코로나바이러스 변종에 의해 발현되는 항원에 대한 항체가 아래에 나열되어 있습니다. 일반적인 코로나바이러스 항체 표적에는 뉴클레오캡시드(N)와 스파이크 당단백질(S)이 포함됩니다. 이 항체는 면역조직화학적 용도로 사용됩니다. 면역조직화학 분석은 SARS-CoV-2 코로나바이러스 Nucleocapsid의 차별적 발현 수준 검출을 보여주고 항체 특이성을 입증합니다. SARS/SARS-CoV-2 코로나바이러스 NP 단일클론 항체(B46F)(카탈로그 번호 MA1-7404)를 사용한 SARS-CoV-2 코로나바이러스 NP의 면역조직화학적 분석은 SARS-CoV-2에 감염된 사람의 폐 및 태반 조직에서 유의미한 염색을 보여줍니다. SARS-CoV-2가 없는 대조 조직과 비교했을 때. 영국과 스웨덴의 연구자들은 최근 매우 민감한 다중 면역조직화학을 사용하여 코로나19 환자와 대조군의 신경학적 증상이 있는 환자의 뇌 주변세포에서 ACE2 발현을 조사했습니다. 그들은 또한 공간적 면역 표현형을 사용하여 코로나19 환자의 뇌 조직의 염증을 평가했습니다.

시장 개요 및 역학

유럽 면역조직화학 시장은 2021년 6억 3,133만 달러에서 2028년 10억 2,227만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 7.1%로 성장할 것으로 예상됩니다. 전통적인 진단 테스트는 일반적으로 고가의 장비를 갖춘 실험실에서 수행되었으며 테스트 수행을 담당하는 숙련된 인력으로 구성되었습니다. 지난 수십 년 동안 진단 테스트는 점차 중앙 실험실에서 벗어나 환자와 가까운 테스트 장소로 발전해 왔습니다. 면역조직화학에 대한 수요 증가와 면역학 연구실의 인력 부족으로 인해 면역조직화학 자동화의 필요성이 대두되었습니다. 면역조직화학(IHC)의 자동화는 감도 수준, 재현성, 표준화를 향상할 수 있는 기회를 제공할 뿐만 아니라 작업 시간 단축 및 시약 절약과 같은 이점도 제공합니다. 분석 유연성은 면역조직화학 프로토콜에 필요한 필수 요소 중 하나입니다. IHC의 자동화는 면역조직화학 기술을 결정적으로 표준화하는 데 기여합니다. 또한 16단계 수작업 방식을 5단계 방식으로 단순화해 작업인원을 최소화하는데도 도움이 된다. 또한 자동화된 면역조직화학은 일관된 품질과 얼룩 배출을 보장하고 다양한 기술의 표준화 및 최적화를 향상시킵니다. 또한, 자동화를 통해 신뢰성 있고 빠른 결과를 통해 더 빠른 속도로 진단 검사 결과를 제공할 수 있어 입원 기간이 단축되어 비용이 절감됩니다. 따라서 면역조직화학(IHC) 자동화가 제공하는 다양한 이점은 수용되어 향후 유럽 시장에서 널리 퍼진 추세 중 하나로 작용할 가능성이 높습니다.

주요 시장 부문

제품 측면에서 항체 부문은 2020년 유럽 면역조직화학 시장에서 가장 큰 점유율을 차지했습니다. 적용 측면에서는 진단 부문이 더 큰 시장 점유율을 차지했습니다. 또한, 병원 및 진단 실험실 부문은 2020년 최종 사용자를 기준으로 유럽 면역조직화학 시장에서 더 큰 점유율을 차지했습니다.  

주요 출처 및 회사 목록에 나와 있습니다.

유럽 면역조직화학 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서 및 통계 등이 있습니다. 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Abcam plc입니다. 애질런트 테크놀로지스, Inc.; 바이오SB; BIO-RAD LABORATORIES INC.; 셀 시그널링 테크놀로지, 인코포레이티드(Cell Signaling Technology, Inc.); 다나허; F. HOFFMANN-LA ROCHE LTD.; 머크 KGaA; 퍼킨엘머 주식회사; 및 THERMO FISHER SCIENTIFIC INC.

보고서 구매 이유

  • 유럽 면역조직화학 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별
  • 끊임없이 변화하는 상황을 이해하여 경쟁에서 앞서 나가십시오. 유럽 면역조직화학 시장의 경쟁 환경
  • 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 유럽 면역조직화학 시장에서 M&A 및 파트너십 거래를 효율적으로 계획
  • 지각적인 관점에서 지식에 기반한 비즈니스 결정을 내리는 데 도움이 됩니다. 유럽 면역조직화학 시장의 다양한 부문의 시장 성과에 대한 종합 분석
  • 2021~2028년 유럽 지역의 다양한 부문별 시장 수익 예측을 얻습니다.

 유럽 면역조직화학 시장 세분화

 유럽 면역조직화학 시장 - 제품별

  • 장비
    • 슬라이드 염색 시스템
    • 조직 마이크로어레이 시스템
    • 조직 처리 시스템
    • 슬라이드 스캐너
    • 기타 장비
  • 항체
    • 1차 항체
    • 2차 항체
  • 시약
    • 조직학적 염색
    • 차단 및 고정 시약
    • 발색성 기질
    • 고정 시약
    • 안정제
    • 유기 용매
    • 단백질 분해 효소
    • 희석제
  • 키트

유럽 면역조직화학 시장 - 용도별

  • 진단
    • 전염병
    • 자가면역질환
    • 당뇨병
    • 신장 질환
    • 기타
  • 약물 검사

유럽 면역조직화학 시장 - 최종 사용자별

  • 병원 및 진단 실험실
  • 연구소
  • 기타

유럽 면역조직화학 시장 - 국가별

  • 영국 
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 유럽 나머지 지역
  • li>

유럽 면역조직화학 시장 - 회사 프로필

  • Abcam plc 
  • Agilent Technologies, Inc.
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Cell Signaling Technology, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA 
  • PerkinElmer Inc.
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Europe Immunohistochemistry Market – By Product

1.3.2        Europe Immunohistochemistry Market – By Application

1.3.3        Europe Immunohistochemistry Market – By End User

1.3.4        Europe Immunohistochemistry Market – By Country

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Europe Immunohistochemistry Market – Market Landscape

4.1       Overview

4.2       Europe PEST Analysis

4.3       Experts Opinion

5.             Europe Immunohistochemistry Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Rising Incidences of Chronic and Infectious Diseases

5.1.2        Growing R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2       Key Market Restraints

5.2.1        Issues Related to Immunohistochemistry

5.3       Key Market Opportunities

5.3.1        Opportunities in Several Countries

5.4       Future Trends

5.4.1        Use of Automation in Immunohistochemistry

5.5       Impact Analysis

6.             Immunohistochemistry Market – Europe Analysis

6.1       Europe Immunohistochemistry Market Revenue Forecast and Analysis

7.             Europe Immunohistochemistry Market Analysis– By Product

7.1       Overview

7.2       Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3       Antibodies

7.3.1        Overview

7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3        Primary Antibodies

7.3.3.1      Overview

7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4        Secondary Antibodies

7.3.4.1      Overview

7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4       Equipment Market

7.4.1        Overview

7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        Slide Staining Systems

7.4.3.1      Overview

7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Tissue Microarrays

7.4.4.1      Overview

7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Tissue Processing Systems

7.4.5.1      Overview

7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Slide Scanners

7.4.6.1      Overview

7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Other Equipments

7.4.7.1      Overview

7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5       Reagents Market

7.5.1        Overview

7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3        Histological Stains

7.5.3.1      Overview

7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4        Blocking Sera & Reagents Market

7.5.4.1      Overview

7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5        Chromogenic Substrates Market

7.5.5.1      Overview

7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6        Stabilizers

7.5.6.1      Overview

7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7        Proteolytic Enzymes

7.5.7.1      Overview

7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8        Organic Solvents

7.5.8.1      Overview

7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9        Fixation Reagents

7.5.9.1      Overview

7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10     Diluents

7.5.10.1    Overview

7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6       Kits Market

7.6.1        Overview

7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8.             Europe Immunohistochemistry Market Analysis – By Application

8.1       Overview

8.2       Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3       Diagnostics

8.3.1        Overview

8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3        Cancer

8.3.3.1      Overview

8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4        Infectious Diseases

8.3.4.1      Overview

8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5        Autoimmune Diseases

8.3.5.1      Overview

8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6        Diabetes Mellitus

8.3.6.1      Overview

8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7        Nephrological Diseases

8.3.7.1      Overview

8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8        Others

8.3.8.1      Overview

8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4       Drug Testing

8.4.1        Overview

8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9.             Europe Immunohistochemistry Market Analysis– By End User

9.1       Overview

9.2       Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3       Hospital & Diagnostic Laboratories

9.3.1        Overview

9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4       Research Institutes

9.4.1        Overview

9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5       Others

9.5.1        Overview

9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.          Europe Immunohistochemistry Market – Country Analysis

10.1    Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

10.1.1     Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1    UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1    UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2    UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.1.2.2        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.1.3    UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.1.3.1        UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.1.4    UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.2    Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1    Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.2.2.2        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.2.3    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.2.3.1        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.2.4    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.3    France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1    France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2    France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.3.2.2        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.3.3    France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.3.3.1        France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.3.4    France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.4    Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1    Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.4.2.2        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.4.3    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.4.3.1        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.4.4    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.5    Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1    Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.2    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.5.2.1        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.5.2.2        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.5.2.3        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.5.3    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.5.3.1        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.5.4    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

10.1.1.6    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.2    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.6.2.1        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

10.1.1.6.2.2        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.6.2.3        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.1.6.3    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

10.1.1.6.3.1        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.1.6.4    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11.          Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market

11.1    Europe: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic developments

12.3.1     Overview

13.          Company Profiles

13.1    Cell Signaling Technology, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    F. HOFFMANN-LA ROCHE LTD.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    MERCK KGaA

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    PerkinElmer Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    THERMO FISHER SCIENTIFIC INC.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Abcam plc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Agilent Technologies, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    BIO-RAD LABORATORIES INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Danaher

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Bio SB

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 7.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 9.             Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 14.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 16.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 21.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 23.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 28.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 29.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 31.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 32.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 33.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 34.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

Table 35.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

Table 36.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

Table 37.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 38.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 39.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 40.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 41.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

Table 42.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 43.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 44.          Organic Developments Done By Companies

Table 45.          Inorganic developments done by Companies

Table 46.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Immunohistochemistry Market Segmentation

Figure 2.           Europe Immunohistochemistry Market Segmentation, By Country

Figure 3.           Europe Immunohistochemistry Market Overview

Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5.           The UK to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market

Figure 8.           Europe Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9.           Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10.        Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30.        Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31.        Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32.        Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33.        Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34.        Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35.        Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36.        Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37.        Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38.        Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39.        Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 43.        Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44.        UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45.        Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46.        France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47.        Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48.        Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49.        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 50.        Impact of COVID-19 Pandemic in European Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC. 
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000